Newsfeeds Archive - Page 3 of 9

4 minute read

Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session

March 28, 2:08 PM

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.

ABTS

5 minute read

Akeso Marks Profit Milestone With Swift Rights Issue

By The Bamboo Works

March 28, 10:58 AM

Key Takeaways: Akeso swung to an annual profit of 1.94 billion yuan, boosted by licensing income of 2.92 billion yuan The next highly anticipated product in the firm’s drug pipeline is ivonescimab, the first PD-1/VEGF bispecific antibody to enter Phase III clinical trials By Molly Wen

SMMT

2 minute read

Analysts Eye Summit Therapeutics’ Ivonescimab As Potential Challenger To Merck’s Keytruda in Lung Cancer Treatment

By Vandana Singh

March 26, 2:36 PM

Stifel covers Summit Therapeutics, highlighting ivonescimab's promise in phase 3 lung cancer trials, potential market expansion worth billions, and a buy rating with $8 target. Updates from Akeso in 2024 and a $5 billion deal add to the optimism, signaling potential share price growth ahead.

MRK

2 minute read

Crude Oil Moves Lower; Summit Therapeutics Shares Plummet

By Avi Kapoor

February 20, 3:33 PM

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 200 points on Tuesday. The Dow traded down 0.18% to 38,557.86 while the NASDAQ fell 1.30% to 15,570.84. The S&P 500 also fell, dropping, 0.73% to 4,969.26.

BFRI

4 minute read

Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Avi Kapoor

February 20, 2:21 PM

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

AGRI

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

February 20, 1:31 PM

Gainers Monopar Therapeutics (NASDAQ:MNPR) shares rose 138.8% to $0.82 during Tuesday’s regular session. The market value of their…

BFRI

2 minute read

Dow Dips Over 100 Points; US Leading Economic Index Falls In January

By Avi Kapoor

February 20, 1:09 PM

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 1.5% on Tuesday. The Dow traded down 0.35% to 38,494.51 while the NASDAQ fell 1.51% to 15,537.95. The S&P 500 also fell, dropping, 0.86% to 4,962.63

AGRI

9 minute read

Earnings

Earnings Scheduled For February 20, 2024

By Benzinga Insights

February 20, 7:52 AM

Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion.

ABCL

3 minute read

Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Avi Kapoor

January 24, 2:05 PM

Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private offering of $160 million of convertible senior notes. BlackBerry shares tumbled 17.2% to $2.9387 on Wednesday.

ANVS

2 minute read

Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session

By Avi Kapoor

January 9, 7:36 AM

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 100 points on Tuesday. Shares of Hewlett Packard Enterprise Company (NYSE: HPE) shares fell sharply in pre-market trading on Tuesday.

CYBR